< 生产厂家 价格 >

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜用途

Quinine 是一种抗疟药, 也是钾通道的抑制剂其 IC50 值为 169 μM。
点击显示

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜名称

[ CAS 号 ]:
130-95-0

[ 中文名 ]:
奎宁

[ 英文名 ]:
Quinine

[中文别名 ]:

[英文别名 ]:

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜生物活性

[ 描述 ]:

Quinine 是一种抗疟药, 也是钾通道的抑制剂其 IC50 值为 169 μM。

[ 相关类别 ]:

信号通路 >> 抗感染 >> 寄生物
信号通路 >> 跨膜转运 >> 钾通道
研究领域 >> 感染

[ 靶点 ]

IC50: 169 μM (potassium channel)[1] Parasite[2]


[参考文献]

[1]. Wrighton DC, et al. Mechanism of inhibition of mouse Slo3 (KCa 5.1) potassium channels by quinine, quinidine and barium. Br J Pharmacol. 2015 Sep;172(17):4355-63.

[2]. Hendriksen IC, et al. Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria. Antimicrob Agents Chemother. 2013 Feb;57(2):775-83.


[相关活性小分子]

尼日利亚菌素钠 | 4-氟-A-(4-氟苯基)-A-苯基-苯甲酰胺 | 硫酸羟基氯喹 | 甲硝唑 | Emetine dihydrochloride hydrate | 伊维菌素 | N-[4-[[1-[2-(6-甲基-2-吡啶基)乙基]-4-哌啶基]羰基]苯基]甲磺酰胺二盐酸盐 | 4-氨基吡啶 | 青蒿素 | 盐酸左旋咪唑 | 氟雷拉纳 | 人参皂苷Rg3 | 1-[(2-氯苯基)二苯甲基]-1H-吡唑 | RRX-001 | 多非利特

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
495.9±40.0 °C at 760 mmHg

[ 熔点 ]:
176-177ºC

[ 分子式 ]:
C20H24N2O2

[ 分子量 ]:
324.417

[ 闪点 ]:
253.7±27.3 °C

[ 精确质量 ]:
324.183777

[ PSA ]:
45.59000

[ LogP ]:
3.44

[ 外观性状 ]:
斜方晶系的针状物，无味

[ 蒸汽压 ]:
0.0±1.3 mmHg at 25°C

[ 折射率 ]:
1.638

[ 储存条件 ]:
2~8°C，避光

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜MSDS

详细MSDS(安全技术说明书)

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VA6020000
CHEMICAL NAME :
Quinine
CAS REGISTRY NUMBER :
130-95-0
LAST UPDATED :
199701
DATA ITEMS CITED :
34
MOLECULAR FORMULA :
C20-H24-N2-O2
MOLECULAR WEIGHT :
324.46
WISWESSER LINE NOTATION :
T66 BNJ HO1 EYQ- DT66 A B CNTJ A1U1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
74 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - visual field changes Sense Organs and Special Senses (Ear) - tinnitus Gastrointestinal - nausea or vomiting
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
294 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Cardiac - other changes Blood - other hemolysis with or without anemia Blood - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
115 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Cardiac - other changes Blood - other hemolysis with or without anemia Blood - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
68 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
180 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
231 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
70 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Bird - pigeon
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Amphibian - frog
DOSE/DURATION :
1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Amphibian - frog
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Blood - other hemolysis with or without anemia
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Amphibian - frog
DOSE/DURATION :
400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
20 mg/kg
SEX/DURATION :
female 4-5 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
27 ug/kg
SEX/DURATION :
female 46-48 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
60 mg/kg
SEX/DURATION :
female 7 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - hepatobiliary system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
10 mg/kg
SEX/DURATION :
female 5 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - abortion Reproductive - Effects on Newborn - stillbirth
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
280 mg/kg
SEX/DURATION :
female 7-8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
650 mg/kg
SEX/DURATION :
female 4-8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death

MUTATION DATA

TYPE OF TEST :
DNA adduct
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
100 umol/L
REFERENCE :
PMSBA4 Progress in Molecular and Subcellular Biology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1969- Volume(issue)/page/year: 2,134,1971 *** REVIEWS *** TOXICOLOGY REVIEW BCSTB5 Biochemical Society Transactions. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1973- Volume(issue)/page/year: 2,695,1974 TOXICOLOGY REVIEW PLMJAP Pahlavi Medical Journal. (Shiraz, Iran) V.1-9, 1970-78. Volume(issue)/page/year: 6,160,1975 TOXICOLOGY REVIEW CLCHAU Clinical Chemistry (Winston-Salem, NC). (American Assoc. for Clinical Chemistry, 1725 K St., NW, Washington, DC 20006) V.1- 1955- Volume(issue)/page/year: 19,361,1973 TOXICOLOGY REVIEW ADVPA3 Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. Volume(issue)/page/year: 4,263,1966 TOXICOLOGY REVIEW FNSCA6 Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. Volume(issue)/page/year: 2,67,1973 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 83470 No. of Facilities: 68 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 68 (estimated)
点击显示

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜安全信息

[ 符号 ]:

GHS08

[ 信号词 ]:
Danger

[ 危害声明 ]:
H315-H317-H319-H334

[ 警示性声明 ]:
P261-P280-P284-P304 + P340-P305 + P351 + P338-P342 + P311

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ 危害码 (欧洲) ]:
Xn:Harmful

[ 风险声明 (欧洲) ]:
R22;R36/37/38

[ 安全声明 (欧洲) ]:
S26-S37/39

[ 危险品运输编码 ]:
UN 1544

[ WGK德国 ]:
3

[ RTECS号 ]:
VA6020000

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1(b)

[ 海关编码 ]:
29392110

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜上下游产品

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜上游产品

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜下游产品

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜制备

1.将金鸡纳树的树皮或根皮去杂，干燥，粉碎后与碱石灰混合均匀。再用石油醚反复抽提，合并提取液，澄清后加入稀硫酸萃取，酸层浓缩结晶后便得硫酸奎宁。制成品有酸性硫酸奎宁和中性硫酸奎宁两种存在形式。酸性硫酸奎宁是一分子硫酸与一分子奎宁所形成的盐，其水溶性好且水溶液呈酸性。中性硫酸奎宁是两分子奎宁与一分硫酸所形成的盐，其水溶液呈中性但水溶性较差。医药常用的是酸性硫酸奎宁。
点击显示

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜海关

[ 海关编码 ]: 29392110

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜文献

Enhancing perception of contaminated food through acid-mediated modulation of taste neuron responses.

Curr. Biol. 24(17) , 1969-77, (2014)

Natural foods contain not only nutrients, but also nonnutritious and potentially harmful chemicals. Thus, animals need to evaluate food content in order to make adequate feeding decisions.Here, we inv...

Synthesis and Characterization of 8-O-Carboxymethylpyranine (CM-Pyranine) as a Bright, Violet-Emitting, Fluid-Phase Fluorescent Marker in Cell Biology.

PLoS ONE 10 , e0133518, (2015)

To avoid spectral interference with common fluorophores in multicolor fluorescence microscopy, a fluid-phase tracer with excitation and emission in the violet end of the visible spectrum is desirable....

Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose.

PLoS ONE 10(2) , e0117240, (2015)

To better understand some aspects of bone matrix glycation, we used an in vitro glycation approach. Within two weeks, our glycation procedures led to the formation of advanced glycation end products (...


更多文献

相关化工产品/化学物质：

相关药品：

推荐生产厂家/供应商：

公司名：上海如吉生物科技发展有限公司

区域：上海市静安区

价格：
￥150.0/10g

联系人：蕾蕾

产品详情：奎宁 金鸡纳碱（进口分装）

公司名：云南西力生物技术股份有限公司

区域：昆明市盘龙区

价格：
￥需询单/50mg

联系人：郑雪平

产品详情：奎宁

公司名：上海吉至生化科技有限公司

区域：上海市奉贤区

价格：
￥585.0/25g ￥185.0/5g ￥78.0/20mg

联系人：刘佳

产品详情：奎宁

公司名：上海脉铂医药科技有限公司

区域：上海市嘉定区

价格：
￥240.0/1g ￥需询单/1g ￥需询单/1g ￥需询单/1g

联系人：李先生

产品详情：奎宁

公司名：上海阿拉丁生化科技股份有限公司

区域：上海市浦东新区

价格：
￥135.9/1ml ￥1646.9/100g ￥525.9/25g ￥146.9/5g

联系人：阿拉丁李高志

产品详情：奎宁

查看所有供应商请点击：

奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜供应商

相关化合物

[奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜]化源网提供奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜CAS号130-95-0，奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜上化源网，专业又轻松。>>电脑版：奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜

标题：130-95-0_奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜CAS号:130-95-0_奎宁； 无水奎宁； 金鸡纳碱； 金鸡纳霜【结构式 性质 英文】 - 化源网 地址：https://m.chemsrc.com/mip/cas/130-95-0_515746.html